Grey Wolf Animal Health Corp.

TSXV:WOLF Stock Report

Market Cap: CA$25.1m

Grey Wolf Animal Health Past Earnings Performance

Past criteria checks 1/6

Grey Wolf Animal Health has been growing earnings at an average annual rate of 81.5%, while the Pharmaceuticals industry saw earnings growing at 32.1% annually. Revenues have been growing at an average rate of 31.6% per year. Grey Wolf Animal Health's return on equity is 2.4%, and it has net margins of 2.4%.

Key information

81.5%

Earnings growth rate

74.3%

EPS growth rate

Pharmaceuticals Industry Growth23.1%
Revenue growth rate31.6%
Return on equity2.4%
Net Margin2.4%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

It's Down 25% But Grey Wolf Animal Health Corp. (CVE:WOLF) Could Be Riskier Than It Looks

Apr 19
It's Down 25% But Grey Wolf Animal Health Corp. (CVE:WOLF) Could Be Riskier Than It Looks

Grey Wolf Animal Health Corp.'s (CVE:WOLF) Shares Not Telling The Full Story

Jan 22
Grey Wolf Animal Health Corp.'s (CVE:WOLF) Shares Not Telling The Full Story

Revenue & Expenses Breakdown

How Grey Wolf Animal Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSXV:WOLF Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23251100
30 Sep 23257100
30 Jun 23245100
31 Mar 23244110
31 Dec 22233110
30 Sep 2222-3100
30 Jun 2219-390
31 Mar 2216-270
31 Dec 2113-160
31 Dec 208-140

Quality Earnings: WOLF has high quality earnings.

Growing Profit Margin: WOLF's current net profit margins (2.4%) are lower than last year (11.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if WOLF's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: WOLF's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: WOLF had negative earnings growth (-76%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (32.7%).


Return on Equity

High ROE: WOLF's Return on Equity (2.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.